Page last updated: 2024-08-21

aminoimidazole carboxamide and Adult Spinal Muscular Atrophy

aminoimidazole carboxamide has been researched along with Adult Spinal Muscular Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Calderó, J; Cerveró, C; Esquerda, JE; Montull, N; Piedrafita, L; Tarabal, O	1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Adult Spinal Muscular Atrophy

Article	Year
Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2016, Volume: 13, Issue:1 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Female; Male; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy, Spinal; Ribonucleotides; Spinal Cord; Treatment Outcome	2016

Article

Year

Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2016, Volume: 13, Issue:1

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Female; Male; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy, Spinal; Ribonucleotides; Spinal Cord; Treatment Outcome

2016